Extreme heat prompts doctors to use body bags as cooling devices for heat stroke; a study of the effect of donanemab on the early stages of Alzheimer disease looks promising; UnitedHealth Group is seeing an influx of people seeking mental health care services, causing accessibility issues because of the provider shortage.
Extreme heat is now a public health emergency, at least according to emergency department doctors in Phoenix, who have created protocols to treat victims of heat stroke with immersive cooling in a body bag filled with ice zipped to shoulder level, according to STAT News. The bags provide an ideal way to treat these patients because they are waterproof, cool the person twice as fast as traditional methods, contain the cooling person and melting ice, and can allow room for intravenous tubing, temperature probes, and intubation if needed. Since the 1960s, heat waves have become more intense, frequent, and prolonged, putting those vulnerable to heat-related illness in danger.
Phase 3 trial results indicate that the earlier the treatment with the experimental drug donanemab, the better for patients with Alzheimer disease, especially when symptoms and brain pathology are mildest, giving a better chance of slowing cognitive decline, reported The New York Times. The study illustrated that donanemab, manufactured by Eli Lilly, can moderately slow the progression of memory and thinking issues in the early stages of Alzheimer disease, with the most progress seen in patients in the early stages when they possessed less of the tau protein that creates tangles in the brain.
UnitedHealth Group reported that the percentage of enrollees getting psychological care was up by double digits since last year, with the shift believed to symbolize long-term change, according to The Wall Street Journal. The payer suggested that people feel more comfortable looking for help for behavioral health issues, but it observes a continuing shortage of mental health care providers that is creating accessibility issues. The increased use of behavioral health care was 1 motivator of higher health care costs highlighted by the company during a call talking about its second-quarter financial results.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More